The structural profiles are close, with Neurocrine Biosciences carrying a narrow edge on stability. Boston Scientific still has the edge on stability, which keeps the comparison from looking entirely one-sided. Both sides have seen trend damage — neither carries a clear market edge right now. With both trends damaged, the structural comparison carries most of the weight here.
The comparison is based on similar long-term financial trajectories, not sector labels.
On stability, the clearer edge sits with Boston Scientific Corporation, while the overall score remains tighter and points the other way.
This comparison is anchored in long-term financial trajectory similarity within the selected peer universe.
This level of similarity signals a strong structural match, even though some dimensions still separate the two companies.
The clearest structural overlap shows up in recent revenue growth and margin consistency.
Scores reflect position relative to comparable companies with similar long-term financial trajectories.
The clearest separation appears in stability.
Left means cheaper relative valuation. Higher means stronger structure.
Neurocrine Biosciences, Inc. and Boston Scientific Corporation look relatively close on structure, but the price setup still leans toward Neurocrine Biosciences, Inc..
Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.
The stability gap is visible, with the stronger side looking materially steadier through time.
Neurocrine Biosciences, Inc. also shows lower market-fundamental divergence, which makes the lead look less detached from the underlying business picture.
Stability is the clearest driver of the lead, with valuation adding further support — though stability still provides a real counterweight.
Break down the BSX vs NBIX comparison across all dimensions with the full interactive tool.
Explore how BSX and NBIX each compare against other companies in their peer groups.
Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.
AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.
Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.
Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.